Completed OBSERVATIONAL NCT03427489

A Biorepository for Coronary Heart Disease in Qatar (QCBio)

A Biorepository for Discovering Novel Biochemical and Genetic Markers of Coronary Heart Disease in Qatar (QCBio)

Sponsor: Hamad Medical Corporation

Updated 10 times since 2018 Last updated: Jul 31, 2018 Started: Jan 31, 2013 Primary completion: Mar 18, 2018 Completion: Mar 18, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Coronary Heart Disease (CHD), this trial is completed. The trial is conducted by Hamad Medical Corporation and has accumulated 10 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Aug 2018 — Nov 2020 [monthly]

Completed

Status: Recruiting → Completed
Jun 2018 — Aug 2018 [monthly]

Recruiting
May 2018 — Jun 2018 [monthly]

Recruiting
Apr 2018 — May 2018 [monthly]

Recruiting

Phase: NA → None
Mar 2018 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hamad Medical Corporation
Mayo Clinic

Data source: Hamad Medical Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Doha, Qatar